ESR1 and invasive breast carcinoma: This is similar to previous studies done in Europe and in the US, that showed the beneficial effect of statins in reducing the risk of recurrence in Stage I-III invasive breast cancers (14, 15, 31–35), and the beneficial effect of statins in reducing the risk of recurrence in ER positive patients (13, 15, 35).